Synergism between Thrombin and Epinephrine in Human Platelets: Different Dose-Response Relationships for Aggregation and Dense Granule Secretion

Summary

Synergism between epinephrine and thrombin in human gel-filtered platelets was studied. Suspensions of platelets, which did not contain added fibrinogen, were incubated at 37° C to measure aggregation and dense granule secretion after stimulation. Both aggregation and secretion induced with 0.03-0.3 U/ml of thrombin were markedly potentiated by epinephrine (0.5-4 ҼM), which alone was without effect. Addition of epinephrine before stimulation with thrombin resulted in a marked decrease in the concentration of thrombin required for half-maximal aggregation, without affecting the maximal aggregation response. The dose-response relationship for dense granule secretion was affected in a similar way with regard to the half-maximal response; in addition, epinephrine slightly increased maximal secretion response. However, the concentration range for thrombin at which synergism occurred was distinctly lower for aggregation than for secretion. Our observations suggest that aggregation and dense granule secretion are separate steps in the sequence of stimulus-response coupling, and suggest distinct thresholds of intracellular messengers for these different responses.

Keywords

Human gel-filtered platelets - Thrombin - Epinephrine - Synergism - Secretion - Aggregation

• References

• 1 O,Brien JR. A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J Clin Pathol 1964; 17: 275-281
• 2 Niewiarowski S, Thomas DP. Platelet aggregation by ADP and thrombin. Nature 1966; 212: 1544-1547
• 3 Ardlie NG, Glew G, Schwartz CJ. Influence of catecholamines on nucleotide-induced platelet aggregation. Nature 1966; 212: 415-4l7
• 4 Mills DC B, Roberts GC K. Effects of adrenaline on human blood platelets. J Physiol 1967; 193: 443-453
• 5 Baumgartner HR, Born GV R. Effects of 5-hydroxytryptamine on platelet aggregation. Nature 1968; 218: 137-141
• 6 Thomas DP. The role of platelet catecholamines in the aggregation of platelets by collagen and thrombin. In: Platelets in Haemostasis. Exp Biol Med 1968; 3: 129-134
• 7 Thomas DP. Effect of catecholamines on platelet aggregation caused by thrombin. Nature 1967; 215: 298-299
• 8 Patscheke H. Role of activation in epinephrine-induced aggregation of platelets. Thromb Res 1980; 17: 133-142
• 9 Hallam TJ, Scrutton MC, Wallis RB. Responses of rabbit platelets to adrenaline induced by other agonists. Thromb Res 1981; 20: 413-424
• 10 Peerschke E IB. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin. Am J Haematol 1984; 16: 335-345
• 11 Steen VM, Holmsen H. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change. Thromb Haemostas 1984; 52: 333-335
• 12 Holmsen H, Storm E, Day HJ. Microdetermination of ADP and ATP in blood platelets - a modification of the plasma method. Anal Biochem 1972; 46: 489-501
• 13 Detwiler TC, Feinman RD. Kinetics of the thrombin-induced release of calcium (II) by platelets. Biochemistry 1973; 12: 282-289
• 14 Detwiler TC, Feinman RD. Kinetics of the thrombin-induced release of adenosine triphosphate by platelets. Comparison with release of calcium. Biochemistry 1973; 12: 2462-2468
• 15 Holmsen H. Are platelet shape change, aggregation and release reaction tangible manifestations of one basic cellular process?. In: Platelets: Production, Function, Transfusion and Storage Ed: Baldini Ebbe. Grune & Stratton Inc; 1974: 207-220
• 16 Holmsen H. Platelet secretion (release reaction)-Mechanism and Pharmacology. Adv Pharmacol Therap 1978; 4: 97-109
• 17 Holmsen H. Mechanisms of platelet secretion. In Platelets: Cellular response, mechanisms and their biological significance Eds Rotman A, Meyer FA, Gitler C, Silberberg A. John Wiley and Sons Ltd; New York: 1980: 249-263
• 18 Berridge MJ. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 1984; 220: 345-360
• 19 Hallam TJ, Thompson NT, Scrutton MC, Rink TJ. The role of cytoplasmic free calcium in the responses of quin2-loaded human platelets to vasopressin. Biochem J 1984; 221: 897-901
• 20 Scrutton MC, Wallis RB. Catecholamine receptors. In: Platelets in Biology and Pathology - 2 Ed: Gordon JL. Elsevier/North-Holland. Biomedical Press; Amsterdam - New York - Oxford: 1981: 180-210
• 21 Cameron HA, Ardlie NG. The facilitating effects of adrenaline on platelet aggregation. Prost Leukotri Med 1982; 9: 117-128
• 22 Jakobs KH, Saur W, Schultz G. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J Cycl Nucleotide Res 1976; 2: 381-392
• 23 Aktories K, Jakobs KH. Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes via a-adrenoceptors. FEBS lett 1981; 130: 235-238
• 24 Haslam RJ, Davidson M ML, Desjardins JV. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J 1978; 176: 83-95
• 25 Feinstein MB, Egan JJ, Sha’afi RI, White J. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGEb forskolin). Biochem Biophys Res Commun 1983; 113: 598-604
• 26 Yamanishi J, Kawahara Y, Fukuzaki H. Effect of cyclic AMP on cytoplasmic free calcium in human platelets stimulated by thrombin: direct measurement with quin-2. Thrombos Res 1983; 32: 183-188
• 27 Zavoico GB, Feinstein MB. Cytoplasmic Ca²⁺ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. Biochem Biophys Res Commun 1984; 120: 579-585